BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29361381)

  • 1. Drug induced pseudolymphoma.
    Magro CM; Daniels BH; Crowson AN
    Semin Diagn Pathol; 2018 Jul; 35(4):247-259. PubMed ID: 29361381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
    Su LD; Duncan LM
    J Cutan Pathol; 2000 May; 27(5):249-54. PubMed ID: 10847550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
    Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
    Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis.
    Magro CM; Crowson AN
    Hum Pathol; 1996 Feb; 27(2):125-32. PubMed ID: 8617453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 Positive Lymphomatoid Angiocentric Drug Reactions: Characterization of a Series of 20 Cases.
    Magro CM; Olson LC; Nguyen GH; de Feraudy SM
    Am J Dermatopathol; 2017 Jul; 39(7):508-517. PubMed ID: 27655118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma.
    Granel B; Serratrice J; Swiader L; Horshowski N; Blaise D; Vey N; Metras D; Habib G; Disdier P; Weiller PJ
    Cancer; 2000 Nov; 89(10):2138-43. PubMed ID: 11066056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of polymerase chain reaction in the detection of clones in lymphoproliferative diseases of the skin.
    Staib G; Sterry W
    Recent Results Cancer Res; 1995; 139():239-47. PubMed ID: 7597295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphomatoid papulosis].
    Dreno B
    Presse Med; 1995 Jun; 24(23):1084-7. PubMed ID: 7567810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous pseudolymphomas.
    Ploysangam T; Breneman DL; Mutasim DF
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):877-95; quiz 896-7. PubMed ID: 9631994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
    Magro CM; Momtahen S
    Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia.
    Magro CM; Crowson AN
    J Am Acad Dermatol; 1995 Mar; 32(3):419-28. PubMed ID: 7868710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Pseudolymphoma.
    Mitteldorf C; Kempf W
    Surg Pathol Clin; 2017 Jun; 10(2):455-476. PubMed ID: 28477891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
    Gallardo F; Costa C; Bellosillo B; Solé F; Estrach T; Servitje O; García-Muret MP; Barranco C; Serrano S; Pujol RM
    Acta Derm Venereol; 2004; 84(6):463-8. PubMed ID: 15844638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
    Gallardo F; Barranco C; Toll A; Pujol RM
    J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary cutaneous CD30+ lymphoproliferative disorders].
    Calzado-Villarreal L; Polo-Rodríguez I; Ortiz-Romero PL
    Actas Dermosifiliogr; 2010 Mar; 101(2):119-28. PubMed ID: 20223154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous lymphomas: new entities and rare variants].
    Kempf W; Mitteldorf C
    Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells.
    Magro CM; Crowson AN; Kovatich AJ; Burns F
    Hum Pathol; 2003 Feb; 34(2):119-29. PubMed ID: 12612879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.